Sergio Traversa, Chief Executive Officer at RELMADA THERAPEUTICS, INC. (RLMD), bought 18,970 shares at $2.91 ($58K) on 2015-12-15, disclosed to the SEC on 2015-12-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.91 | 5,600 | $16K | 28.2% |
| 2 | $2.92 | 241 | $704 | 1.2% |
| 3 | $2.98 | 2,370 | $7K | 12.2% |
| 4 | $2.99 | 2,759 | $8K | 14.3% |
| 5 | $3.00 | 4,358 | $13K | 22.6% |
| 6 | $3.34 | 200 |
| $668 |
| 1.2% |
| 7 | $3.39 | 42 | $142 | 0.2% |
| 8 | $3.40 | 1,600 | $5K | 9.4% |
| 9 | $3.42 | 1,800 | $6K | 10.7% |
| Total | $3.05 avg | 18,970 | $58K | 100% |
| Filing → |
| RLMD | BUY | 2025-11-06 | $600K | — | Filing → |
| RLMD | BUY | 2025-08-28 | $265K | — | Filing → |
| RLMD | BUY | 2025-05-20 | $335K | — | Filing → |